WASHINGTON — In one of their first acts of 2020, state lawmakers will attempt to bring a vanquished bill back from the dead.
Lawmakers in New Hampshire next month are set to consider a proposed ban on generic drug “price gouging” — the latest in a series of attempts by statehouses to tackle prescription drug costs. But as most state legislatures around the country pursue new, aggressive ideas to lower drug prices, the Granite State is revisiting a bill largely left for dead after a federal court struck down Maryland’s version two years ago.
National drug pricing advocates are hoping New Hampshire’s version will fare better — and ultimately serve as a harbinger of more sweeping change. If the bill becomes law and survives a legal challenge, dozens of other states could take up the effort, too, alongside a bevy of other laws aimed at lowering drug costs.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect